T-Cell Mediated Inflammation in Postmenopausal Osteoporosis.
Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R.
Front Immunol. 2021 Jun 30;12:687551. doi: 10.3389/fimmu.2021.687551. eCollection 2021.
Modulation of the Inflammatory Response and Bone Healing.
Maruyama M, Rhee C, Utsunomiya T, Zhang N, Ueno M, Yao Z, Goodman SB.
Front Endocrinol (Lausanne). 2020 Jun 11;11:386. doi: 10.3389/fendo.2020.00386. eCollection 2020.
Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions.
Komatsu N, Takayanagi H.
Nat Rev Rheumatol. 2022 Jul;18(7):415-429. doi: 10.1038/s41584-022-00793-5. Epub 2022 Jun 15.
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis.
Iwaszko M, Biały S, Bogunia-Kubik K.
Cells. 2021 Nov 3;10(11):3000. doi: 10.3390/cells10113000.
Osteoarthritis year in review 2023: Biology.
Roelofs AJ, De Bari C.
Osteoarthritis Cartilage. 2024 Feb;32(2):148-158. doi: 10.1016/j.joca.2023.11.002. Epub 2023 Nov 7.
Therapeutic potential of intermittent hypoxia: a matter of dose.
Navarrete-Opazo A, Mitchell GS.
Am J Physiol Regul Integr Comp Physiol. 2014 Nov 15;307(10):R1181-97. doi: 10.1152/ajpregu.00208.2014. Epub 2014 Sep 17.
Myokines: The endocrine coupling of skeletal muscle and bone.
Gomarasca M, Banfi G, Lombardi G.
Adv Clin Chem. 2020;94:155-218. doi: 10.1016/bs.acc.2019.07.010. Epub 2019 Aug 8.
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.
Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP.
Pharmacol Ther. 2008 Feb;117(2):244-79. doi: 10.1016/j.pharmthera.2007.10.001. Epub 2007 Oct 26.
Role of inflammation in the aging bones.
Abdelmagid SM, Barbe MF, Safadi FF.
Life Sci. 2015 Feb 15;123:25-34. doi: 10.1016/j.lfs.2014.11.011. Epub 2014 Dec 13.
Resolution of inflammation in bone regeneration: From understandings to therapeutic applications.
Newman H, Shih YV, Varghese S.
Biomaterials. 2021 Oct;277:121114. doi: 10.1016/j.biomaterials.2021.121114. Epub 2021 Sep 1.
